Goulart, H., Jabbour, E., Jain, N., Ravandi, F., Kadia, T., DiNardo, C., Daver, N., Pemmaraju, N., Bataller, A., Haddad, F., Khouri, R., Senapati, J., Garris, R., Kantarjian, H. (2025). Consolidation with CAR T-cell therapy may abrogate the need for allogeneic stem cell transplant in patients with relapsed B-cell acute lymphoblastic leukemia after receiving dose-dense mini-hyper-CVD with inotuzumab ozogamicin and blinatumomab. Blood. https://doi.org/10.1182/blood-2025-3350